March 13, 2026
avatar-torie-bosch
First Opinion editor

In First Opinion this week, Lawrence Diller, a behavioral/developmental pediatrician from California, writes about an underexplored factor that might be contributing to the rise in autism diagnoses: Parents want insurance coverage of expensive therapy.

But perhaps what I found most interesting about the piece is the way that Diller, who has been practicing in the Bay Area for 45 years, describes parents’ changing attitudes around autism. “In the early 1980s, when faced with how to present to parents an explanation of their children’s problems, doctors wanted to avoid the absolutely devastating prognosis of autism,” he writes. “They would focus instead on these other diagnoses to offer parents some hope for a connection to their child.”

Now, instead of begging him not to diagnose their children with autism, parents seek the label out. I love personal essays in which long-practicing physicians reflect on societal changes and how they show up in the exam room.

Indeed, I think that change, especially within the author or the author’s field, is the key to a really great first-person. That arc lends itself to an enlightening op-ed.

Have you changed your mind about something in health care? Has your field undergone a change that hasn’t been widely discussed? Want to write about it? Let me know.

Recommendation of the week: In the Atlantic, Katherine J. Wu gives a chilling warning: “Florida Is Trying to Ignore Measles Until It Can’t” (gift link).



STEFANI REYNOLDS/AFP via Getty Images

America must not learn to live with 72,000 overdose deaths a year

If the U.S. becomes complacent about drug overdose deaths, funding will decrease and difficult choices won’t be made.

By Wayne Kepner


STAT+ | How surrealism helps us make sense of and live with dementia

Surrealism helps us feel what it is like to live with dementia and offers clever, subversive ways to live creatively with it.

By Jason Karlawish


America has health alarm fatigue. I know because I treat it

U.S. public health is in the ICU and the alarms are constant. Vigilance can’t save us, but protocols can.

By Robert B. Shpiner


Genentech founders Herbert W. Boyer, left, and Robert A. Swanson.
Courtesy Genentech

STAT+ | It’s the 50th anniversary of the U.S. biotech industry. What will the next 50 years look like?

2026 marks the 50th anniversary of the U.S. biotech industry. What will the next 50 years look like? BIO's John Crowley weighs in.

By John F. Crowley


I’m an NIH whistleblower. The scientific community cannot afford to avoid politics

NIH whistleblower Jenna Norton argues that scientists must speak up as science comes under threat.

By Jenna Norton


I’m a medical student. RFK Jr. is right about medical school and preventive care

Preventive and lifestyle-based approaches continue to receive little emphasis in medical education.

By Lauren Rice


Molly Ferguson for STAT

STAT+ | The Himsification of medicine

Hims has created a new mode of medicine, in which patients are consumers racing to buy into products and practices that feel aspirational and cutting-edge

By Vishal Khetpal


The financial reason why parents beg me to diagnose their kids with autism

A behavioral/developmental pediatrician has watched autism rates rise as parents seek financial support for therapy.

By Lawrence Diller


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.